Green Fresh Biotechnology Company Limited (Green Fresh Bio) secured full shareholder endorsement for every motion tabled at its Annual General Meeting held on 12 June 2026, according to poll results released by the company.

All nine ordinary resolutions passed with overwhelming support. Key outcomes include:

• Financials adopted: 100% of the 532.30 million votes cast approved the audited consolidated financial statements and directors’ and auditor’s reports for the year ended 31 December 2025.

• Dividend declared: Shareholders unanimously sanctioned a final dividend of HK1.2 cents per share for FY 2025.

• Board continuity: Executive directors Mr Chan Kam Chung and Ms Chen Yi, together with independent non-executive director Mr Ho Kwai Ching, Mark, were each re-elected with 100% support. The board was also authorised to set directors’ remuneration.

• Auditor re-appointment: PricewaterhouseCoopers was re-appointed as auditor with 99.99% approval, and its remuneration will be determined by the board.

• Capital mandates: Shareholders granted the board full mandates to repurchase shares and to issue new shares, as well as to extend the issue mandate by the amount of any repurchased shares. Each motion received at least 99.99% support.

Participation metrics show that 532.30 million votes were cast from the 874.12 million shares outstanding, representing the entire shareholding eligible to vote. No shareholders abstained, and no votes were lodged against the majority of resolutions. Computershare Hong Kong Investor Services acted as scrutineer, and all directors attended the meeting in person or electronically.